Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000066

President and CEO sold 1,000 shares at $15.00 ($15,000)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2023-09-13 Sale 10b5-1 −1,000 $15.00 $15,000 248,279 D: show line 1 in the form
Open-market sales · 1,000 sh · avg $15.00 · $15,000
Loading xslF345X05/wf-form4_169480928381353.xml…